Health
Subset of COVID-19 patients have increased bleeding risk – EurekAlert
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
The human body strives to keep itself in homeostasis, or balance. When blood clots are created, the body’s innate response is to break the clots down to prevent significant health problems from arising.
Research has found that patients with COVID-19 are prone to serious blood clotting. This is why many patients receive high dose anticoagulants as part of their treatment.
But a new study in Scientific Reports, led by senior author Daniel Lawrence, Ph.D., a Professor of Basic Research in Cardiovascular…
-
Noosa News20 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News20 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
General17 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business9 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?